Amylyx Pharmaceuticals Statistics
NASDAQ: AMLXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
26.02-0.18 (-0.69%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Amylyx Pharmaceuticals by the numbers
Amylyx Pharmaceuticals has a market capitalization of $3.35 billion based on 128.56M shares outstanding. With trailing EPS of $-1.43, Amylyx Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.4% below its 50-day average and 23.2% above its 200-day average.
Average daily trading volume is 1.53M shares, or about $39.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AMLX valuation vs. peer median
| Metric | AMLX | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.35B | $3.37B | -1% |
| Avg. volume | 1.53M | 2.36M | -35% |
Peer median across 8 companies: VRDN, ARQT, IRON, ELVN, PBLS, ABCL, VKTX, XERS.
Valuation
- Market cap
- $3.35B
- EPS (TTM)
- $-1.43
- Shares outstanding
- 128.56M
Price and trading
- Previous close
- 26.20
- Open
- 25.64
- Day range
- 25.52 – 26.40
- 52-week range
- 10.83 – 41.14
- 52-week change
- +77.37%
- Beta
- —
- Volume
- 1.14M
- Average volume
- 1.53M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 3.35B
- Forward Pe
- -22.07
- Eps
- -1.43
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 41.14
- Week52 Low
- 10.83
- Avg Volume
- 1.53M
- Shares Outstanding
- 128.56M
- Ma50
- 29.05
- Ma200
- 21.12
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -36.75%
- Pct From52w Low
- 140.26%